(This story is for CNBC PRO subscribers only.)
Here are the biggest calls on Wall Street on Friday:
Rosenblatt said in its initiation of the chipmaker that it should benefit as consumers upgrade to 5G capable phones.
"We are launching coverage on QCOM with a Buy rating and a $105 12-month target price. Qualcomm will not only benefit from the 5G handset upgrade but will also lead the market in establishing 5G capabilities worldwide. We expect that Qualcomm's dollar content per handset to increase 25% to 50% compared with 4G handsets. Important, in our view, is Qualcomm's 5G platform strategy in expanding the company's markets beyond handsets."
"The combination of record low healthcare utilization for traditional procedures and services caused by the COVID-19 outbreak with an anticipation for a bolus of consumption as restrictions ease has created a challenging period for Managed Care Organizations (MCOs). This dynamic coupled with severe and sharp unemployment poses risks from an enrollment and pricing perspective which is all playing out during an election year where the healthcare system will be in even greater focus. That said, we believe the MCOs by and large will be able to navigate this extraordinary window of time through investing in their offerings (and members) this year with an eye on disciplined pricing for next year."